MALAT1, a lncRNA that is upregulated in different solid and hematological tumors and that has been associated with cancer metastasis and recurrence [131, 140, 141], seems to be involved in chemotherapy sensitivity in DLBCL cell lines by enhancing autophagy-related proteins [142]. Here, MALAT1 is linked to diffuse large B-cell lymphoma.